Los puntos clave no están disponibles para este artículo en este momento.
Gene editing, particularly through CRISPR-Cas9 technology, represents a transformative advancement in medicine, agriculture, and research. CRISPR-Cas9 works by using a guide RNA (gRNA) to precisely target a specific DNA sequence, allowing the Cas9 enzyme to cut the DNA at that location. The cell then repairs the break, either introducing small mutations or using a provided template for precise corrections. This ability to accurately modify genes has made CRISPR-Cas9 a powerful tool for addressing genetic disorders like cystic fibrosis and sickle cell disease, offering potential cures by correcting the underlying genetic defects.
Isabella Zhao (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: